Eisai Co. Ltd.

In News

Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation - Eisai

Eisai - Mar 17, 2026

Number of shareholders of Eisai Co., Ltd. – TSE:4523 - TradingView

TradingView - May 09, 2026

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease - Biogen

Biogen - May 08, 2026

Eisai Co Ltd stock (JP3160400002): Japanese pharma giant with global Alzheimer's focus - AD HOC NEWS

AD HOC NEWS - May 12, 2026

Eisai Co., Ltd. and Biogen Inc. Update on Fda Priority Review of Leqembi Iqlik (Lecanemab-Irmb) Subcutaneous Injection as A Starting Dose for Early Alzheimer's Disease - marketscreener.com

marketscreener.com - May 08, 2026

Eisai strikes Japan licensing deal with Shanghai Henlius Biotech - Reuters

Reuters - Feb 05, 2026

VCs back Tortugas to advance Eisai, Hansoh neurology compounds: Venture Report - BioCentury

BioCentury - Apr 23, 2026

Earnings call transcript: Eisai’s Q3 2025 revenue grows, stock rises 1.81% - Investing.com

Investing.com - Feb 09, 2026

Eisai to Launch “Pariet® S,” the First Proton Pump Inhibitor RX-to-OTC in Japan - Eisai

Eisai - Jun 02, 2025

Eisai Co., Ltd. Reports Preliminary Sales Results for the First Quarter 2026 - marketscreener.com

marketscreener.com - Apr 29, 2026

EISAI TO BEGIN ENROLLING PHASE 2 STUDY IN PATIENTS WITH NARCOLEPSY - PR Newswire

PR Newswire - Mar 26, 2026

Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO® (Lemborexant) in China - Eisai

Eisai - Aug 18, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment